Baxter Cash on Hand 2010-2025 | BAX

Baxter cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Baxter cash on hand for the quarter ending March 31, 2025 was $2.294B, a 24.19% decline year-over-year.
  • Baxter cash on hand for 2024 was $1.764B, a 42.69% decline from 2023.
  • Baxter cash on hand for 2023 was $3.078B, a 79.16% increase from 2022.
  • Baxter cash on hand for 2022 was $1.718B, a 41.78% decline from 2021.
Baxter Annual Cash on Hand
(Millions of US $)
2024 $1,764
2023 $3,078
2022 $1,718
2021 $2,951
2020 $3,730
2019 $3,335
2018 $1,838
2017 $3,394
2016 $2,801
2015 $7,361
2014 $2,925
2013 $2,733
2012 $3,270
2011 $2,905
2010 $2,685
2009 $2,786
Baxter Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $2,294
2024-12-31 $1,764
2024-09-30 $1,420
2024-06-30 $2,095
2024-03-31 $3,026
2023-12-31 $3,078
2023-09-30 $5,788
2023-06-30 $1,722
2023-03-31 $1,673
2022-12-31 $1,718
2022-09-30 $1,601
2022-06-30 $1,852
2022-03-31 $2,294
2021-12-31 $2,951
2021-09-30 $3,258
2021-06-30 $3,136
2021-03-31 $3,182
2020-12-31 $3,730
2020-09-30 $4,359
2020-06-30 $4,085
2020-03-31 $4,110
2019-12-31 $3,335
2019-09-30 $3,009
2019-06-30 $2,925
2019-03-31 $1,908
2018-12-31 $1,838
2018-09-30 $2,860
2018-06-30 $2,857
2018-03-31 $2,947
2017-12-31 $3,394
2017-09-30 $3,517
2017-06-30 $3,817
2017-03-31 $2,858
2016-12-31 $2,801
2016-09-30 $2,597
2016-06-30 $2,630
2016-03-31 $3,443
2015-12-31 $7,361
2015-09-30 $6,126
2015-06-30 $6,680
2015-03-31 $2,530
2014-12-31 $2,925
2014-09-30 $2,078
2014-06-30 $1,866
2014-03-31 $2,049
2013-12-31 $2,733
2013-09-30 $2,376
2013-06-30 $5,989
2013-03-31 $2,689
2012-12-31 $3,270
2012-09-30 $3,191
2012-06-30 $2,353
2012-03-31 $2,272
2011-12-31 $2,905
2011-09-30 $2,338
2011-06-30 $2,018
2011-03-31 $2,168
2010-12-31 $2,685
2010-09-30 $2,788
2010-06-30 $2,300
2010-03-31 $2,673
2009-12-31 $2,786
2009-09-30 $2,571
2009-06-30 $1,802
2009-03-31 $1,703
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.842B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.294B 27.81
Boston Scientific (BSX) United States $157.073B 39.32
Stryker (SYK) United States $146.485B 30.63
EssilorLuxottica (ESLOY) France $131.510B 0.00
Medtronic (MDT) Ireland $104.117B 14.76
Haleon (HLN) United Kingdom $50.587B 28.80
Lonza Group Ag (LZAGY) Switzerland $49.544B 0.00
ResMed (RMD) United States $36.103B 27.12
GE HealthCare Technologies (GEHC) United States $32.514B 15.44
Agilent Technologies (A) United States $31.721B 20.95
Terumo (TRUMY) Japan $28.131B 36.54
Insulet (PODD) United States $22.987B 90.23
Koninklijke Philips (PHG) Netherlands $21.694B 15.60
Zimmer Biomet Holdings (ZBH) United States $18.639B 11.97
Smith & Nephew SNATS (SNN) United Kingdom $12.666B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.269B 21.81
Lantheus Holdings (LNTH) United States $5.242B 13.22
Prestige Consumer Healthcare (PBH) United States $4.244B 18.96
Perrigo (PRGO) Ireland $3.757B 9.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.266B 14.88
ICU Medical (ICUI) United States $3.210B 23.67
Envista Holdings (NVST) United States $3.051B 25.35
GN Store Nord (GNNDY) Denmark $2.163B 17.92
QuidelOrtho (QDEL) United States $2.114B 14.54
LeMaitre Vascular (LMAT) United States $1.868B 41.76
AtriCure (ATRC) United States $1.683B 0.00
Neogen (NEOG) United States $1.335B 17.08
Acuren (TIC) United States $1.317B 0.00
AdaptHealth (AHCO) United States $1.256B 12.75
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
BioLife Solutions (BLFS) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.919B 9.26
Evolus (EOLS) United States $0.633B 0.00
CeriBell (CBLL) United States $0.625B 0.00
Curaleaf Holdings (CURLF) Canada $0.590B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.568B 0.00
Valneva SE (VALN) France $0.534B 0.00
Owens & Minor (OMI) United States $0.509B 4.22
Capricor Therapeutics (CAPR) United States $0.479B 0.00
Tilray Brands (TLRY) Canada $0.446B 0.00
Surmodics (SRDX) United States $0.412B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.339B 0.00
Cresco Labs (CRLBF) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
Canopy Growth (CGC) Canada $0.313B 0.00
Aurora Cannabis (ACB) Canada $0.307B 54.70
Sanara MedTech (SMTI) United States $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 22.00
ZimVie (ZIMV) United States $0.245B 11.11
Cerus (CERS) United States $0.241B 0.00
Sanuwave Health (SNWV) United States $0.239B 0.00
Verano Holdings (VRNOF) United States $0.237B 0.00
Biote (BTMD) United States $0.223B 6.28
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
OraSure Technologies (OSUR) United States $0.207B 0.00
Brainsway (BWAY) Israel $0.201B 53.25
Quanterix (QTRX) United States $0.197B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.185B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.46
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.136B 16.69
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.114B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Agape ATP (ATPC) $0.092B 0.00
Fonar (FONR) United States $0.089B 11.42
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.071B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.039B 13.47
Rockwell Medical (RMTI) United States $0.033B 0.00
Nephros (NEPH) United States $0.031B 41.86
Safety Shot (SHOT) United States $0.029B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00